In the UK, mifepristone and gemeprost are licensed for medical termination of pregnancy (TOP) 
Background
The Royal College of Obstetricians and Gynaecologists (RCOG) in its evidence-based guidelines in 2000 1 stated that 'ideally, abortion services must be able to offer a choice of recommended methods for relevant gestation bands'. In the RCOG audit of abortion services in the same year it found that fewer than 25% of National Health Service (NHS) hospitals offered both medical and surgical terminations in the first trimester. 2 The licensed regime for medical termination of pregnancy (TOP) involves the administration of oral mifepristone 600 mg followed 48 hours later by 1 mg vaginal gemeprost (Cervagem ® ). 3 The regime is, however, only licensed in the first trimester up to 63 days of amenorrhoea. Following World Health Organization (WHO) guidelines 4 most units now use a regime of 2000mg mifepristone followed by the vaginal administration of 800 mg misoprostol. This regime offers the advantage of much reduced costs and the fact that misoprostol is easier to store and handle than Cervagem. A similar regime using multiple doses of misoprostol is now well recognised for management of TOP in the second trimester.
Medical TOP in the late first trimester has been described in a very recent study. 5 We describe here a further large cohort study using medical termination in the first trimester of pregnancy after 63 days amenorrhoea.
Methods

All patients attending the Integrated Termination of Pregnancy Service in Sheffield from January 2000 to
December 2002 requesting first-trimester TOP were offered either a surgical or a medical procedure. All patients were offered an ultrasound scan to confirm gestation and screening for sexually transmitted infections.
Those patients who chose a medical procedure were given 200 mg mifepristone, usually at the Central Family Planning Clinic in Sheffield. They returned 48 hours later to the Termination Unit at the Royal Hallamshire Hospital for their prostaglandins. The initial treatment was 800 mg misoprostol given vaginally and this was repeated 6-hourly up to a maximum of four doses. Ultrasound facilities are available on the unit if required but are not used routinely to confirm abortion. All patients are given emergency contact numbers after their discharge and are offered a follow-up appointment at the Central Family Planning Clinic.
Results
During the trial period 415 patients with 63-84 days amenorrhoea requested medical TOP (Table 1) . Gestation was confirmed by ultrasound in 413 patients (99.5%).
One patient did not attend for her prostaglandins. There was no record of her continuing the pregnancy in the district or of being admitted to hospital and it was assumed that she had miscarried. There were some minor deviations from protocol in those patients receiving multiple doses of prostaglandins (Table 2) . A total of 314 (76%) patients agreed to have a 100 mg diclofenac suppository at the time of their first misoprostol administration, 160 (39%) had additional oral analgesia, 97 (24%) had 50 mg intramuscular pethidine and 154 (37%) had no additional analgesia.
Complete abortion occurred in 392 (94.6%) patients and 375 (91%) patients were managed as day cases. There were three (0.7%) ongoing pregnancies requiring surgical termination. There were 11 (2.6%) patients who required 
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surgical intervention at the time of the procedure on account of retained products and haemorrhage. Eight patients had evidence of retained products after discharge home requiring further treatment, either surgically or with further prostaglandins.
Conclusions
Medical TOP in the late first trimester using the regime described has an acceptable success rate. When judged by the efficacy of medical termination in the early part of the first trimester the results are comparable ( Table 3 ). The slightly higher ongoing pregnancy rate necessitates effective follow-up for those patients who do not abort during their time in the termination unit.
The need for surgical intervention at the time of abortion in over 2% of patients suggests that this technique may not be suitable for TOP outside of the setting of an established gynaecological unit. Our results do indicate, however, that it appears to be an acceptable method of termination in the late first trimester and can be safely introduced into a wider practice. 
